UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population

Clinical genitourinary cancer, 2014-10, Vol.12 (5), p.354-358

2014

Volltextzugriff (PDF)

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

The New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300

2021

Volltextzugriff (PDF)

Low-dose Ultraviolet B Rays Alter the mRNA Expression of the Circadian Clock Genes in Cultured Human Keratinocytes

Journal of investigative dermatology, 2002-12, Vol.119 (6), p.1220-1223

2002

Volltextzugriff (PDF)

Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population

Urologic oncology, 2023-07, Vol.41 (7), p.328.e15-328.e23

2023

Volltextzugriff (PDF)

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma

Canadian Urological Association journal, 2019-06, Vol.13 (6), p.166-174

2019

Volltextzugriff (PDF)

Circadian expression of clock genes in human oral mucosa and skin: Assocoiation with specific cell-cycle phases

The American journal of pathology, 2001-05, Vol.158 (5), p.1793

2001

Volltextzugriff (PDF)

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3584-3590

2009

Volltextzugriff (PDF)

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

The Lancet (British edition), 2021-02, Vol.397 (10275), p.695-703

2021

Volltextzugriff (PDF)

Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma

Molecular cancer, 2014-05, Vol.13 (1), p.101-101, Article 101

2014

Volltextzugriff (PDF)

miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation

The Journal of urology, 2011-09, Vol.186 (3), p.1077-1083

2011

Volltextzugriff (PDF)

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

Molecular cancer, 2009-03, Vol.8 (1), p.20-20, Article 20

2009

Volltextzugriff (PDF)

Venous Thromboembolic Disease: The Use of the Aspiration Thrombectomy Device AngioVac

Seminars in interventional radiology, 2015-12, Vol.32 (4), p.374-378

2015

Volltextzugriff (PDF)

miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma

The Journal of molecular diagnostics : JMD, 2015-03, Vol.17 (2), p.136-144

2015

Volltextzugriff (PDF)

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Molecular therapy, 2015-11, Vol.23 (11), p.1748-1758

2015

Volltextzugriff (PDF)

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2018-04, Vol.378 (14), p.1277-1290

2018

Volltextzugriff (PDF)

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma

Oncotarget, 2014-01, Vol.5 (2), p.506-518

2014

Volltextzugriff (PDF)

ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade

Human pathology, 2022-02, Vol.120, p.57-70

2022

Volltextzugriff (PDF)

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2023-04, Vol.41 (11), p.1965-1971

2023

Volltextzugriff (PDF)

Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis

The American journal of surgical pathology, 2017-12, Vol.41 (12), p.1618-1629

2017

Volltextzugriff (PDF)

The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma

The Journal of molecular diagnostics : JMD, 2012-07, Vol.14 (4), p.385-392

2012

Volltextzugriff (PDF)

Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance

Molecular & cellular proteomics, 2013-01, Vol.12 (1), p.132-144

2013

Volltextzugriff (PDF)

Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (5), p.543-553

2011

Volltextzugriff (PDF)

S100A11 is a potential prognostic marker for clear cell renal cell carcinoma

Clinical & experimental metastasis, 2016-01, Vol.33 (1), p.63-71

2016

Volltextzugriff (PDF)

Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy

Molecular oncology, 2018-10, Vol.12 (10), p.1673-1688

2018

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(39)
Bücher
(2)

Sprache

Englisch
(40)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(23)
Male
(14)
Oncology
(14)
Female
(12)
Kidney Neoplasms - Pathology
(12)
Carcinoma, Renal Cell - Genetics
(10)
Carcinoma, Renal Cell - Drug Therapy
(9)
Kidney Cancer
(9)
Kidney Neoplasms - Drug Therapy
(9)
Kidney Neoplasms - Genetics
(9)
Middle Aged
(9)
Prognosis
(9)
Biomarkers, Tumor - Genetics
(8)
Carcinoma, Renal Cell - Mortality
(8)
Metastasis
(8)
Renal Cell Carcinoma
(8)
Aged
(7)
Carcinoma, Renal Cell - Pathology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Low-dose Ultraviolet B Rays Alter the mRNA Expression of the Circadian Clock Genes in Cultured Human Keratinocytes

Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma

Circadian expression of clock genes in human oral mucosa and skin: Assocoiation with specific cell-cycle phases

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma

miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

Venous Thromboembolic Disease: The Use of the Aspiration Thrombectomy Device AngioVac

miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma

ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis

The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma

Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance

Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

S100A11 is a potential prognostic marker for clear cell renal cell carcinoma

Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy

Suchergebnisse filtern